Skip to content

Gross Profit at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
iRadimed logo
iRadimedIRMD
$16.81M+13.3%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$16.38M-52.0%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$296.4M+27.8%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$4.46M-68.1%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$21.49M-24.2%

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.5%
Enterprise value$95.86M-31.3%
P/S2.5×-2.5×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Calculated from Rapid Micro Biosystems’s reported figures.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's gross profit?
Rapid Micro Biosystems (RPID) reported gross profit of $371K in Q1 2026.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.